Proteome Sciences Plc (PRM.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -75 | 126 | -8 | 43 | 7 |
| Other Working Capital | 209 | -90 | 253 | 156 | -162 |
| Other Operating Activity | -1,275 | -1,290 | -1,788 | -1,485 | -1,557 |
| Operating Cash Flow | $-1,141 | $-1,254 | $-1,543 | $-1,286 | $-1,712 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -45 | -10 | -104 | -52 |
| Purchase Of Investment | -226 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-234 | $-45 | $-10 | $-104 | $-52 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 336 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 4,248 | 389 | N/A | 4,673 | 418 |
| Common Stock Repurchased | N/A | N/A | N/A | -563 | N/A |
| Other Financing Activity | -42 | -21 | -8 | -19 | -19 |
| Financing Cash Flow | $4,542 | $368 | $-8 | $4,091 | $399 |
| Exchange Rate Effect | -316 | -75 | 15 | -67 | 139 |
| Beginning Cash Position | 79 | 1,423 | 2,989 | 364 | 1,575 |
| End Cash Position | 2,930 | 417 | 1,443 | 2,998 | 349 |
| Net Cash Flow | $3,167 | $-931 | $-1,561 | $2,701 | $-1,365 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,141 | -1,254 | -1,543 | -1,286 | -1,712 |
| Capital Expenditure | -8 | -45 | -22 | -104 | -52 |
| Free Cash Flow | -1,149 | -1,299 | -1,565 | -1,390 | -1,764 |